Key clinical point : Adoptive transfer of donor-derived T cells represents a potentially life-saving strategy for patients with progressive multifocal leukoencephalopathy.
Major finding : Seven of 12 patients stabilized and, in some cases, experienced significant neurological improvement.
Study details : A pilot study including 12 patients with refractory PML.
Disclosures: The study was funded by NINDS. The investigators disclosed no conflicts related to the study.
Citation: Cortese I et al. AAN 2019, Abstract Plen01.002.